179 related articles for article (PubMed ID: 12060642)
1. Thalidomide metabolism by the CYP2C subfamily.
Ando Y; Fuse E; Figg WD
Clin Cancer Res; 2002 Jun; 8(6):1964-73. PubMed ID: 12060642
[TBL] [Abstract][Full Text] [Related]
2. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
Yamazaki H; Shimada T
Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
[TBL] [Abstract][Full Text] [Related]
3. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients.
Teo SK; Sabourin PJ; O'Brien K; Kook KA; Thomas SD
J Biochem Mol Toxicol; 2000; 14(3):140-7. PubMed ID: 10711629
[TBL] [Abstract][Full Text] [Related]
5. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
6. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
Gentile DM; Verhoeven CH; Shimada T; Back DJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):975-82. PubMed ID: 9864282
[TBL] [Abstract][Full Text] [Related]
7. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
Graham MJ; Bell AR; Crewe HK; Moorcraft CL; Walker L; Whittaker EF; Lennard MS
Xenobiotica; 2003 Mar; 33(3):225-37. PubMed ID: 12637241
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
9. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD
J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
[TBL] [Abstract][Full Text] [Related]
10. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
[TBL] [Abstract][Full Text] [Related]
11. Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies.
Schmider J; Greenblatt DJ; von Moltke LL; Harmatz JS; Duan SX; Karsov D; Shader RI
Pharmacology; 1996 Feb; 52(2):125-34. PubMed ID: 8851634
[TBL] [Abstract][Full Text] [Related]
12. Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes.
Roos PH; Mahnke A
Biochem Pharmacol; 1996 Jul; 52(1):73-84. PubMed ID: 8678911
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1.
Ozawa S; Ohta K; Miyajima A; Kurebayashi H; Sunouchi M; Shimizu M; Murayama N; Matsumoto Y; Fukuoka M; Ohno Y
Xenobiotica; 2000 Oct; 30(10):1005-17. PubMed ID: 11315102
[TBL] [Abstract][Full Text] [Related]
14. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R
J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2002 May; 30(5):602-7. PubMed ID: 11950794
[TBL] [Abstract][Full Text] [Related]
16. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates.
Zhao K; Ding M; Cao H; Cao ZX
J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
18. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
Wester MR; Lasker JM; Johnson EF; Raucy JL
Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
Stearns RA; Chakravarty PK; Chen R; Chiu SH
Drug Metab Dispos; 1995 Feb; 23(2):207-15. PubMed ID: 7736913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
